These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 15660501)
21. The metabolic syndrome and its cardiovascular manifestations. Sánchez-Torres RJ; Delgado-Osorio H Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068 [TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Lee SC; Pu YB; Thomas GN; Lee ZS; Tomlinson B; Cockram CS; Critchley JA; Chan JC Metabolism; 2000 Aug; 49(8):1021-4. PubMed ID: 10954020 [TBL] [Abstract][Full Text] [Related]
23. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Abete I; Goyenechea E; Zulet MA; Martínez JA Nutr Metab Cardiovasc Dis; 2011 Sep; 21 Suppl 2():B1-15. PubMed ID: 21764273 [TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome: treatment of hypertensive patients. Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215 [TBL] [Abstract][Full Text] [Related]
26. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome]. Hashimoto N; Saito Y Nihon Rinsho; 2000 Feb; 58(2):405-10. PubMed ID: 10707566 [TBL] [Abstract][Full Text] [Related]
27. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Grundy SM Nat Rev Drug Discov; 2006 Apr; 5(4):295-309. PubMed ID: 16582875 [TBL] [Abstract][Full Text] [Related]
28. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Salmenniemi U; Ruotsalainen E; Pihlajamäki J; Vauhkonen I; Kainulainen S; Punnonen K; Vanninen E; Laakso M Circulation; 2004 Dec; 110(25):3842-8. PubMed ID: 15596567 [TBL] [Abstract][Full Text] [Related]
29. Management of metabolic syndrome in children and adolescents. Pacifico L; Anania C; Martino F; Poggiogalle E; Chiarelli F; Arca M; Chiesa C Nutr Metab Cardiovasc Dis; 2011 Jun; 21(6):455-66. PubMed ID: 21565479 [TBL] [Abstract][Full Text] [Related]
30. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults. Appel SJ; Harrell JS; Davenport ML J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162 [TBL] [Abstract][Full Text] [Related]
31. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555 [TBL] [Abstract][Full Text] [Related]
32. Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome. Davidson MH Am J Cardiol; 2004 Jun; 93(11A):3C-11C. PubMed ID: 15178511 [TBL] [Abstract][Full Text] [Related]
33. Protective and ameliorative effects of maté (Ilex paraguariensis) on metabolic syndrome in TSOD mice. Hussein GM; Matsuda H; Nakamura S; Akiyama T; Tamura K; Yoshikawa M Phytomedicine; 2011 Dec; 19(1):88-97. PubMed ID: 22018902 [TBL] [Abstract][Full Text] [Related]